Acute inflammatory myelopathies

Handbook of Clinical Neurology

Volumn 122, Issue , 2014, Pages 613-667

  Cree, Bruce A C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute transverse myelitis; Cerebrospinal fluid; Inflammation; Neuromyelitis optica; Partial myelitis; Pediatric transverse myelitis; Progressive necrotic myelopathy

Indexed keywords

ACUTE DISEASE; ACUTE TRANSVERSE MYELITIS; ANIMAL; ARTICLE; CEREBROSPINAL FLUID; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; IMMUNOLOGY; INFLAMMATION; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; PARTIAL MYELITIS; PATHOLOGY; PEDIATRIC TRANSVERSE MYELITIS; PROGRESSIVE NECROTIC MYELOPATHY; RECURRENT DISEASE;

ACUTE TRANSVERSE MYELITIS; CEREBROSPINAL FLUID; INFLAMMATION; NEUROMYELITIS OPTICA; PARTIAL MYELITIS; PEDIATRIC TRANSVERSE MYELITIS; PROGRESSIVE NECROTIC MYELOPATHY;

ACUTE DISEASE; ANIMALS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; MULTIPLE SCLEROSIS; MYELITIS; RECURRENCE;

EID: 84893481132     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52001-2.00027-3     Document Type: Chapter

References (394)

1. Adams R.D., Kubik C.S. The morbid anatomy of the demyelinative disease. Am J Med 1952, 12:510-546.
2. Agarwal M.P., Giri S., Sharma V., et al. Concurrent reactive arthritis and myelitis - a case report. Int Arch Med 2009, 2:17.
3. Agre P., Nielsen S. The aquaporin family of water channels in kidney. Nephrologie 1996, 17:409-415.
4. Aguilera A.J., Carlow T.J., Smith K.J., et al. Lymphocytaplasmapheresis in Devic's syndrome. Transfusion 1985, 25:54-56.
5. Ahn B.O., Kang K.K., Ahn G.J., et al. Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury. Int J Impot Res 2003, 15:405-411.
6. Akman-Demir G., Serdaroglu P., Tasci B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. J Neurol Brain 1999, 122:2171-2182.
7. Aksamit A.J. Neurosarcoidosis. Continuum 2008, 14:181-196.
8. al Deeb S.M., Yaqub B.A., Bruyn G.W., et al. Acute transverse myelitis. A localized form of postinfectious encephalomyelitis. J Neurol Brain 1997, 120:1115-1122.
9. Alarcon-Segovia D., Perez-Vazquez M.E., Villa A.R., et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Arth Rheum Semin Arthritis Rheum 1992, 21:275-286.
10. Alexander G.E., Provost T.T., Stevens M.B., et al. Sjögren syndrome: central nervous system manifestations. Neurology 1981, 31:1391-1396.
11. Alexander E.L., Malinow K., Lejewski J.E., et al. Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 1986, 104:323-330.
12. Alper G., Petropoulou K.A., Fitz C.R., et al. Idiopathic acute transverse myelitis in children: an analysis and discussion of MRI findings. Mult Scler 2011, 17:74-80.
13. Altrocchi P.H. Acute transverse myelopathy. Arch Neurol 1963, 9:111-119.
14. Altrocchi P.H. Acute transverse myelopathy. Trans Am Neurol Assoc 1963, 88:186-188.
15. Amiry-Moghaddam M., Frydenlund D.S., Ottersen O.P. Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport. Neuroscience 2004, 129:999-1010.
16. Anderson D.W., Borsaru A. Case report: Lymphoma-related resolving paraneoplastic myelopathy with MRI correlation. Br J Radiol 2008, 81:e103-e105.
17. Andronikou S., Albuquerque-Jonathan G., Wilmshurst J., et al. MRI findings in acute idiopathic transverse myelopathy in children. Pediatr Radiol 2003, 33:624-629.
18. Antoine J.C., Camdessanche J.P., Absi L., et al. Devic disease and thymoma with anti-central nervous system and antithymus antibodies. Neurology 2004, 62:978-980.
19. April R.S., Vansonnenberg E. A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Clinicopathologic report and review of the literature. Neurology 1976, 26:1066-1070.
20. Arabshahi B., Pollock A.N., Sherry D.D., et al. Devic disease in a child with primary Sjögren syndrome. J Child Neurol 2006, 21:285-286.
21. Aszkanazy C.L. Sarcoidosis of the central nervous system. J Neuropahtol Exp Neurol 1952, 11:392-400.
22. Attwood W., Poser C.M. Neurologic complications of Sjögren's syndrome. Neurology 1961, 11:1034-1041.
23. Aukrust P., Lien E., Kristoffersen A.K., et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency - possible immunologic and clinical consequences. Blood 1996, 87:674-681.
24. Avcin T., Benseler S.M., Tyrrell P.N., et al. A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arth Rheum 2008, 59:206-213.
25. Averbuch-Heller L., Steiner I., Abramsky O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol 1992, 49:1292-1295.
26. Bakker J., Metz L. Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG). Can J Neurol Sci 2004, 31:265-267.
27. Banerjee T., Hunt W.E. Spinal cord sarcoidosis. Case report. J Neurosurg 1972, 36:490-493.
28. Banwell B.L. The long (-itudinally extensive) and the short of it: transverse myelitis in children. Neurology 2007, 68:1447-1449.
29. Banwell B., Kennedy J., Sadovnick D., et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009, 72:232-239.
30. Barile-Fabris L., Ariza-Andraca R., Olguin-Ortega L., et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 2005, 64:620-625.
31. Bartolucci P., Brechignac S., Cohen P., et al. Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients. Lupus 2007, 16:817-822.
32. Baruah J.K., Glasauer F.E., Sil R., et al. Sarcoidosis of the cervical spinal canal: case report. Neurosurgery 1978, 3:216-218.
33. Bashir K., Whitaker J.N. Importance of paraclinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI. Mult Scler 2000, 6:312-316.
34. Bastian H.C. Special disease of the spinal cord. A Dictionary of Medicine 1882, 1474-1477. D. Appleton, New York. 5th edn. R. Quain (Ed.).
35. Bastian H.C. Observations on thrombotic softening of the spinal cord: a missuse of so called "acute myelitis". Lancet 1910, 176:1531-1534.
36. Beck R.W., Chandler D.L., Cole S.R., et al. Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses. Ann Neurol 2002, 51:481-490.
37. Behar A.J., Feldman S., Halpern L. Subacute necrotic myelopathy with bulbar involvement. Confin Neurol 1957, 17:329-338.
38. Behçet H. Uber residivierende, aphtöse, durch ein virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Derm Woschenscr 1937, 105:1152-1157.
39. Bennett J.L., Lam C., Kalluri S.R., et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009, 66:617-629.
40. Berman M., Feldman S., Alter M., et al. Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981, 31:966-971.
41. Bernard G., Riou E., Rosenblatt B., et al. Simultaneous Guillain-Barré syndrome and acute disseminated encephalomyelitis in the pediatric population. J Child Neurol 2008, 23:752-757.
42. Bertsias G.K., Ioannidis J.P., Aringer M., et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010, 69:2074-2082.
43. Bhinder S., Harbour K., Majithia V. Transverse myelitis, a rare neurological manifestation of mixed connective tissue disease - a case report and a review of literature. Clin Rheumatol 2007, 26:445-447.
44. Bichuetti D.B., Lobato de Oliveira E.M., Oliveira D.M., et al. Neuromyelitis optica treatment: analysis of 36 patients. Arch Neurol 2010, 67:1131-1136.
45. Birnbaum J., Kerr D. Devic's syndrome in a woman with systemic lupus erythematosus: diagnostic and therapeutic implications of testing for the neuromyelitis optica IgG autoantibody. Arth Rheum 2007, 57:347-351.
46. Birnbaum J., Kerr D. Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus. Nat Clin Pract Rheumatol 2008, 4:381-386.
47. Birnbaum J., Petri M., Thompson R., et al. Distinct subtypes of myelitis in systemic lupus erythematosus. Arth Rheum 2009, 60:3378-3387.
48. Blackwood W. Spinal thrombophelebitis. Greenfield's Neuropathology 1963, Wilkins & Wilkins, Baltimore. W.H. Blackwood, A. Meyer, R.M. Norman (Eds.).
49. Bolat S., Berding G., Dengler R., et al. Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis. J Neurol Sci 2009, 287:257-259.
50. Bolla G., Disdier P., Verrot D., et al. Acute transverse myelitis and primary urticarial vasculitis. Clin Rheumatol 1998, 17:250-252.
51. Bonnan M., Valentino R., Olindo S., et al. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler 2009, 15:487-492.
52. Bradl M., Misu T., Takahashi T., et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009, 66:630-643.
53. Brown J.J., Murphy M.J. Transverse myelopathy in progressive systemic sclerosis. Ann Neurol 1985, 17:615-617.
54. Brown-Séquard C.M. De la transmission des impressions sensitives par la moelle epinière. Compt Rend Soc Biol 1849, 1:192-194.
55. Bruna J., Martinez-Yelamos S., Martinez-Yelamos A., et al. Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler 2006, 12:169-173.
56. Bynke H., Olsson J.E., Rosen I. Diagnostic value of visual evoked response, clinical eye examination and CSF analysis in chronic myelopathy. Acta Neurol Scand 1977, 56:55-69.
57. Cabrera-Gomez J., Saiz-Hinarejos A., Graus F., et al. Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders. Mult Scler 2008, 14:248-251.
58. Calguneri M., Onat A.M., Ozturk M.A., et al. Transverse myelitis in a patient with Behçet's disease: favorable outcome with a combination of interferon-alpha. Clin Rheumatol 2005, 24:64-66.
59. Campos L.M., Kiss M.H., D'Amico E.A., et al. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus 2003, 12:820-826.
60. Candler P.M., Hart P.E., Barnett M., et al. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry 2004, 75:1411-1415.
61. Capobianco M., Malucchi S., di Sapio A., et al. Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease). Neurol Sci 2007, 28:209-211.
62. Case records of the Massachusetts General Hospital Weekly clinicopathological exercises. Case 26-1976. N Engl J Med 1976, 294:1447-1454.
63. Chahin S., Garwood M.D., St Louis E.K., et al. Intramedullary Sjögren syndrome. Neurology 2009, 73:2041-2042.
64. Chan K.H., Vernino S., Lennon V.A. ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol 2001, 50:301-311.
65. Chan K.H., Tsang K.L., Fong G.C., et al. Idiopathic inflammatory demyelinating disorders after acute transverse myelitis. Eur J Neurol 2006, 13:862-868.
66. Cheng W., Chiu R., Tam P. Residual bladder dysfunction 2 to 10 years after acute transverse myelitis. J Paediatr Child Health 1999, 35:476-478.
67. Christensen P.B., Wermuth L., Hinge H.H., et al. Clinical course and long-term prognosis of acute transverse myelopathy. Acta Neurol Scand 1990, 81:431-435.
68. Clark E.C., Bailey A.A. Neurologic and psychiatric findings in lupus erythematosus. Trans Am Neurol Assoc 1954, 13:15-18.
69. Cohen-Aubart F., Galanaud D., Grabli D., et al. Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study. Medicine 2010, 89:133-140.
70. Comi G., Martinelli V., Rodegher M., et al. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet 2009, 374:1503-1511.
71. Cordonnier C., de Seze J., Breteau G., et al. Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol 2003, 250:1447-1452.
72. Cree B.A., Wingerchuk D.M. Acute transverse myelitis: is the "idiopathic" form vanishing?. Neurology 2005, 65:1857-1858.
73. Cree B.A., Goodin D.S., Hauser S.L. Neuromyelitis optica. Semin Neurol 2002, 22:105-122.
74. Cree B.A., Lamb S., Morgan K., et al. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005, 64:1270-1272.
75. Cross S.A., Salomao D.R., Parisi J.E., et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 2003, 54:38-50.
76. D'Antona S. Sulla necrosi spinale acuta nel corso dei tumori maligni, con un contributo alla conoscenza delle "ernie spinali malaciche". Neurologica 1926, 3:65.
77. Dahbour S.S. MRI documented acute myelitis in a patient with Vogt-Koyanagi-Harada syndrome: first report. Clin Neurol Neurosurg 2009, 111:200-202.
78. DaJusta D.G., Wosnitzer M.S., Barone J.G. Persistent motor deficits predict long-term bladder dysfunction in children following acute transverse myelitis. J Urol 2008, 180(Suppl):1774-1777.
79. Dansey R.D., Hammond-Tooke G.D., Lai K., et al. Subacute myelopathy: an unusual paraneoplastic complication of Hodgkin's disease. Med Pediatr Oncol 1988, 16:284-286.
80. Day A.L., Sypert G.W. Spinal cord sarcoidosis. Ann Neurol 1977, 1:79-85.
81. D'Cruz D.P., Mellor-Pita S., Joven B., et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol 2004, 31:280-285.
82. De Camilli P., Thomas A., Cofiell R., et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J Exp Med 1993, 178:2219-2223.
83. De Goede C.G., Holmes E.M., Pike M.G. Acquired transverse myelopathy in children in the United Kingdom - a 2 year prospective study. Eur J Paediatr Neurol 2010, 14:479-487.
84. De Santis G., Caniatti L., De Vito A., et al. A possible paraneoplastic neuromyelitis optica associated with lung cancer. Neurol Sci 2009, 30:397-400.
85. de Seze J., Devos D., Castelnovo G., et al. The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis. Neurology 2001, 57:1359-1363.
86. de Seze J., Lanctin C., Lebrun C., et al. Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology 2005, 65:1950-1953.
87. Debette S., de Sèze J., Pruvo J.P., et al. Long-term outcome of acute and subacute myelopathies. J Neurol 2009, 256:980-988.
88. Defresne P., Meyer L., Tardieu M., et al. Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry 2001, 71:272-274.
89. Defresne P., Meyer L., Tardieu M., et al. Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry 2001, 71:272-274.
90. Defresne P., Hollenberg H., Husson B., et al. Acute transverse myelitis in children: clinical course and prognostic factors. J Child Neurol 2003, 18:401-406.
91. Delalande S., de Seze J., Fauchais A.L., et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine 2004, 83:280-291.
92. Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 1977, 87:336-345.
93. Deshpande D.M., Krishnan C., Kerr D.A. Transverse myelitis after lumbar steroid injection in a patient with Behçet's disease. Spinal Cord 2005, 43:735-737.
94. Dinkin M.J., Cestari D.M., Stein M.C., et al. NMO antibody-positive recurrent optic neuritis without clear evidence of transverse myelitis. Arch Ophthalmol 2008, 126:566-570.
95. Dolan A.L., Gibson T. Intrinsic spinal cord lesions in 2 patients with ankylosing spondylitis. J Rheumatol 1994, 21:1160-1161.
96. Drach L.M., Enzensberger W., Fabian T., et al. Paraneoplastic necrotising myelopathy in a case of AIDS with lymphoma. J Neurol Neurosurg Psychiatry 1996, 60:237.
97. Dubey N., Miletich R.S., Wasay M., et al. Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis. J Neurol Sci 2002, 205:77-81.
98. Dunne K., Hopkins I.J., Shield L.K. Acute transverse myelopathy in childhood. Dev Med Child Neurol 1986, 28:198-204.
99. Edwards M.K., Farlow M.R., Stevens J.C. Cranial MR in spinal cord MS: diagnosing patients with isolated spinal cord symptoms. AJNR Am J Neuroradiol 1986, 7:1003-1005.
100. Erickson T.C., Odom G., Stern K. Boeck's disease (sarcoid) of the central nervous system: report of a case, with complete clinical and pathologic study. Arch Neurol Psychiatry 1942, 48:613-621.
101. Espinosa G., Mendizabal A., Minguez S., et al. Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients. Semin Arthritis Rheum 2010, 39:246-256.
102. Feasby T.E., Ferguson G.G., Kaufmann J.C. Isolated spinal cord arteritis. Can J Neurol Sci 1975, 2:143-146.
103. Feindel R. Uber akute aufsteigende Rückenmarksnekrose. Z ges Neurol Psychiat 1921, 68:147.
104. Ferreira S., Marques P., Carneiro E., et al. Devic's syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome. Rheumatology 2005, 44:693-695.
105. Ferrell A.S., Tubbs R.S., Acakpo-Satchivi L., et al. Legacy and current understanding of the often-misunderstood Foix-Alajouanine syndrome. Historical vignette. J Neurosurg 2009, 111:902-906.
106. Filippi M., Martinelli V., Locatelli T., et al. Acute- and insidious-onset myelopathy of undetermined aetiology: contribution of paraclinical tests to the diagnosis of multiple sclerosis. J Neurol 1990, 237:171-176.
107. Filippi M., Rovaris M., Inglese M., et al. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet 2004, 364:1489-1496.
108. Flechtner K.M., Baum K. Mixed connective tissue disease: recurrent episodes of optic neuropathy and transverse myelopathy. Successful treatment with plasmapheresis. J Neurol Sci 1994, 126:146-148.
109. Foix C., Alajouanine T. La myélite nécrotique subaiguë. Myélite centrale angio-hypertrophique à évolution progressive, paraplégie amyotrophique lentement ascendante, d'abord spasmodique, puis flasque, s'accompagnant de dissociation albuminocytologique. Rev Neurol 1926, 33:1-42.
110. Folliss A.G.H., Netsky M.G. Progressive necrotic myelopathy. Handbook of Clinical Neurology 1970, Vol. 9:452-468. North-Holland Publishing, Amsterdam. P.J. Vinken, G.W. Bruyn (Eds.).
111. Ford B., Tampieri D., Francis G. Long-term follow-up of acute partial transverse myelopathy. Neurology 1992, 42:250-252.
112. Franciotta D., Zardini E., Caporali R., et al. Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis. J Neurol Sci 2011, 303:139-141.
113. Fukae J., Noda K., Fujishima K., et al. Subacute longitudinal myelitis associated with Behçet's disease. Intern Med 2010, 49:343-347.
114. Fukazawa T., Hamada T., Tashiro K., et al. Acute transverse myelopathy in multiple sclerosis. J Neurol Sci 1990, 100:217-222.
115. Fukazawa T., Moriwaka F., Mukai M., et al. Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand 1993, 88:184-189.
116. Fulford K.W., Catterall R.D., Delhanty J.J., et al. A collagen disorder of the nervous system presenting as multiple sclerosis. Brain 1972, 95:373-386.
117. Gajofatto A., Monaco S., Fiorini M., et al. Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. Arch Neurol 2010, 67:724-730.
118. Ganesan V., Borzyskowski M. Characteristics and course of urinary tract dysfunction after acute transverse myelitis in. Dev Med Child Neurol 2001, 43:473-475.
119. Gieron M.A., Margraf L.R., Korthals J.K., et al. Progressive necrotizing myelopathy associated with leukemia: clinical, pathologic, and MRI correlation. J Child Neurol 1987, 2:44-49.
120. Glantz M.J., Biran H., Myers M.E., et al. The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer 1994, 73:168-175.
121. Gökçay F., Celebisoy N., Gökçay A., et al. Primary Sjögrens syndrome presenting as neuromyelitis optica. Pediatr Neurol 2007, 36:58-60.
122. Goodman B.P., Driver-Dunckley E.D., Leslie K.O., et al. A case of gait unsteadiness-an atypical manifestation of an unusual disease. Lancet Neurol 2007, 6:1029-1032.
123. Govender R., Wieselthaler N.A., Ndondo A., et al. Acquired demyelinating disorders of childhood in the Western Cape, South Africa. J Child Neurol 2010, 25:48-56.
124. Gowers W.R. A Manual of Diseases of the Nervous System. Disease of the nerves and spinal cord 1899, Vol. 1:344-376. P. Blackstone's, Philadelphia. 3rd edn. W.R.S. Gowers, S. Taylor (Eds.).
125. Graber J.J., Allie S.R., Mullen K.M., et al. Interleukin-17 in transverse myelitis and multiple sclerosis. J Neuroimmunol 2008, 196:124-132.
126. Graham W., Ogryzlo M.A. Ankylosing (Marie-Strumpell) spondylitis; an analysis of 100 cases. Can Med Assoc J 1947, 57:16-21.
127. Gray F., Hauw J.J., Escourolle R., et al. Necrotic myelopathies and neoplastic pathologie. Three clinico-pathological cases (author's transl). Rev Neurol 1980, 136:235-246.
128. Green A.L., Mitchell P.J. Spinal cord Neurobehçet's disease detected on magnetic resonance imaging. Australas Radiol 2000, 44:201-203.
129. Greenberg B.M., Thomas K.P., Krishnan C., et al. Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology 2007, 68:1614-1617.
130. Gregoire S.M., Mormont E., Laloux P., et al. Atopic myelitis: a clinical, biological, radiological and histopathological diagnosis. J Neurol Sci 2006, 247:231-235.
131. Grignani G., Gobbi P.G., Piccolo G., et al. Progressive necrotic myelopathy as a paraneoplastic syndrome: report of a case and some pathogenetic considerations. J Intern Med 1992, 231:81-85.
132. Grisold W., Lutz D., Wolf D. Necrotizing myelopathy associated with acute lymphoblastic leukemia. Case report and review of literature. Acta Neuropathol 1980, 49:231-235.
133. Hamilton A.J., Whitehead D.J., Bull M.D., et al. Systemic panca-associated vasculitis with central nervous involvement causing recurrent myelitis: case report. BMC Neurol 2010, 10:118.
134. Hamnik S.E., Hacein-Bey L., Biller J., et al. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations. Semin Ophthalmol 2008, 23:191-200.
135. Handforth A., Nag S., Sharp D., et al. Paraneoplastic subacute necrotic myelopathy. Can J Neurol Sci 1983, 10:204-207.
136. Harbitz F. Unknown forms of arteritis with special reference to their relation to syphilitic arteritis and periarteritis nodosa. Am J Med Sci 1922, 163:250-272.
137. Harmouche H., Mouti O., el-Alaoui Faris M., et al. Acute myelitis and Behçet's disease: three case reports. Rev Med Interne 2000, 21:1047-1051.
138. Harris E.N., Gharavi A.E., Mackworth-Young C.G., et al. Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies. Ann Rheum Dis 1985, 44:281-283.
139. Harrison P.E. Granulomatous angitis of the central nervous system. Case report and review. J Neurol Sci 1976, 29:335-341.
140. Harzheim M., Schlegel U., Urbach H., et al. Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci 2004, 217:217-223.
141. Herring A.B., Urich H. Sarcoidosis of the central nervous system. J Neurol Sci 1969, 9:405-422.
142. Heymann D.L., Aylward R.B. Eradicating polio. N Engl J Med 2004, 351:1275-1277.
143. Hillmen P., Young N.S., Schubert J., et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006, 355:1233-1243.
144. Hinson S.R., Pittock S.J., Lucchinetti C.F., et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69:2221-2231.
145. Hirai T., Korogi Y., Hamatake S., et al. Case report: varicella-zoster virus myelitis - serial MR findings. Br J Radiol 1996, 69:1187-1190.
146. Hoffman H.L. Acute necrotic myelopathy. Brain 1955, 78:377-394.
147. Hopkins I.J. A new syndrome: poliomyelitis-like illness associated with acute asthma in childhood. Aust Paediatr J 1974, 10:273-276.
148. Howell K.B., Wanigasinghe J., Leventer R.J., et al. Concomitant transverse myelitis and acute motor axonal neuropathy in an adolescent. Pediatr Neurol 2007, 37:378-381.
149. Hu J., Verkman A.S. Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. FASEB J 2006, 20:1892-1894.
150. Hubbe P., Mouritzen Dam A. Spastic paraplegia of unknown origin. A follow-up of 32 patients. Acta Neurol Scand 1973, 49:536-542.
151. Hughes M., Ahern V., Kefford R., et al. Paraneoplastic myelopathy at diagnosis in a patient with pathologic stage 1A Hodgkin disease. Cancer 1992, 70:1598-1600.
152. Hume A.L., Waxman S.G. Evoked potentials in suspected multiple sclerosis: diagnostic value and prediction of clinical course. J Neurol Sci 1988, 83:191-210.
153. Hummers L.K., Krishnan C., Casciola-Rosen L., et al. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 2004, 62:147-149.
154. Icoz S., Tuzun E., Kurtuncu M., et al. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients. Int J Neurosci 2010, 120:71-75.
155. Jacob A., Weinshenker B.G., Violich I., et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol 2008, 65:1443-1448.
156. Jacob A., Weinshenker B.G., Violich I., et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol 2008, 65:1443-1448.
157. Jacob A., Matiello M., Weinshenker B.G., et al. Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol 2009, 66:1128-1133.
158. Jaffe D., Freeman W. Spinal necrosis and softening of obscure origin. Necrotic myelitis versus myelomalacia; review of literature and clinicopathological case studies. Arch Neurol Psychiatr (Chic) 1943, 49:683-707.
159. James D.G., Sharma O.P., Bradstreet P. The Kveim-Siltzbach test. Report of a new British antigen. Lancet 1967, 2:1274-1275.
160. Javed A., Balabanov R., Arnason B.G., et al. Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis. Mult Scler 2008, 14:809-814.
161. Jefferson M. Sarcoidosis of the nervous system. Brain 1957, 80:540-556.
162. Jeffery D.R. Chronic progressive myelopathy: diagnostic analysis of cases with and without sensory involvement. J Neurol Sci 1996, 142:153-156.
163. Jeffery D.R., Mandler R.N., Davis L.E. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 1993, 50:532-535.
164. Joseph F.G., Scolding N.J. Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry 2009, 80:297-304.
165. Juba A. Myelitis necroticans subacuta (Foix-Alajouanine). Deutsch Z Nervenheilk 1938, 148:17.
166. Kahlenberg J.M. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndrome. Semin Arthritis Rheum 2011, 40:343-348.
167. Kahloon A.A., Arif H., Baig S.M., et al. Characteristics of acute transverse myelitis at Aga Khan University Hospital, Karachi. J Pak Med Assoc 2007, 57:215-218.
168. Kalita J., Misra U.K. Is methyl prednisolone useful in acute transverse myelitis?. Spinal Cord 2001, 39:471-476.
169. Kalita J., Misra U.K. Is methyl prednisolone useful in acute transverse myelitis?. Spinal Cord 2001, 39:471-476.
170. Kalluri S.R., Illes Z., Srivastava R., et al. Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica. Arch Neurol 2010, 67:1201-1208.
171. Kalra V., Sharma S., Sahu J., et al. Childhood acute transverse myelitis: clinical profile, outcome, and association with antiganglioside antibodies. J Child Neurol 2009, 24:466-471.
172. Kaplin A.I., Deshpande D.M., Scott E., et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest 2005, 115:2731-2741.
173. Karussis D., Leker R.R., Ashkenazi A., et al. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?. Ann Neurol 1998, 44:629-634.
174. Katsiari C.G., Giavri I., Mitsikostas D.D., et al. Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation. Eur J Neurol 2011, 18:556-563.
175. Katz J.D., Ropper A.H. Progressive necrotic myelopathy: clinical course in 9 patients. Arch Neurol 2000, 57:355-361.
176. Keegan M., Pineda A.A., McClelland R.L., et al. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002, 58:143-146.
177. Kerr D., Chrishnan C., Pidcock F. Acute transverse myelitis. Treatment of Pediatric Neurologic Disorders 2005, 445-451. Taylor and Francis, Boca Raton, FL. H. Singer, E.H. Kossoff, A.L. Hartman, T.O. Crawford (Eds.).
178. Kidd D., Steuer A., Denman A.M., et al. Neurological complications in Behçet's syndrome. Brain 1999, 122:2183-2194.
179. Kikuchi H., Osoegawa M., Ochi H., et al. Spinal cord lesions of myelitis with hyperIgEemia and mite antigen specific IgE (atopic myelitis) manifest eosinophilic inflammation. J Neurol Sci 2001, 183:73-78.
180. Kim K.K. Idiopathic recurrent transverse myelitis. Arch Neurol 2003, 60:1290-1294.
181. Kim S.M., Waters P., Vincent A., et al. Sjögren's syndrome myelopathy: spinal cord involvement in Sjögren's syndrome might be a manifestation of neuromyelitis optica. Mult Scler 2009, 15:1062-1068.
182. Kim S.K., Im H.J., Kim W., et al. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis. Clin Nucl Med 2010, 35:67-70.
183. Kim S.H., Kim W., Park M.S., et al. Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica. Arch Neurol 2011, 68:473-479.
184. Kira J., Harada M., Yamaguchi Y., et al. Hyperprolactinemia in multiple sclerosis. J Neurol Sci 1991, 102:61-66.
185. Kira J., Yamasaki K., Kawano Y., et al. Acute myelitis associated with hyperIgEemia and atopic dermatitis. J Neurol Sci 1997, 148:199-203.
186. Kira J., Kawano Y., Yamasaki K., et al. Acute myelitis with hyperIgEaemia and mite antigen specific IgE: atopic myelitis. J Neurol Neurosurg Psychiatry 1998, 64:676-679.
187. Kira J., Osoegawa M., Horiuchi I., et al. History of allergic disorders in common neurologic diseases in Japanese patients. Acta Neurol Scand 2002, 105:215-220.
188. Kira J., Isobe N., Kawano Y., et al. Atopic myelitis with focal amyotrophy: a possible link to Hopkins syndrome. J Neurol Sci 2008, 269:143-151.
189. Kocer N., Islak C., Siva A., et al. CNS involvement in neuro-Behçet syndrome: an MR study. AJNR Am J Neuroradiol 1999, 20:1015-1024.
190. Kolodny E.H., Rebeiz J.J., Caviness V.S., et al. Granulomatous angiitis of the central nervous system. Arch Neurol 1968, 19:510-524.
191. Konttinen Y.T., Kinnunen E., von Bonsdorff M., et al. Acute transverse myelopathy successfully treated with plasmapheresis and prednisone in a patient with primary Sjögren's syndrome. Arth Rheum 1987, 30:339-344.
192. Kovacs B., Lafferty T.L., Brent L.H., et al. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 2000, 59:120-124.
193. Kumar N., Hagan J.B., Abraham R.S., et al. Common variable immunodeficiency-associated myelitis: report of treatment with infliximab. J Neurol 2008, 255:1821-1824.
194. Kuroda Y., Miyahara M., Sakemi T., et al. Autopsy report of acute necrotizing opticomyelopathy associated with thyroid cancer. J Neurol Sci 1993, 120:29-32.
195. Lahat E., Pillar G., Ravid S., et al. Rapid recovery from transverse myelopathy in children treated with methylprednisolone. Pediatr Neurol 1998, 19:279-282.
196. Lalive P.H., Menge T., Barman I., et al. Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology 2006, 67:176-177.
197. Lan H.H., Chen D.Y., Chen C.C., et al. Combination of transverse myelitis and arachnoiditis in cauda equina syndrome of long-standing ankylosing spondylitis: MRI features and its role in clinical management. Clin Rheumatol 2007, 26:1963-1967.
198. Lannuzel A., Lamaury I., Charpentier D., et al. Neurological manifestations of Behçet's disease in a Caribbean population: clinical and imaging findings. J Neurol 2002, 249:410-418.
199. Lavalle C., Pizarro S., Drenkard C., et al. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol 1990, 17:34-37.
200. Lee S.H., Yoon P.H., Park S.J., et al. MRI findings in neuro-Behçet's disease. Clin Radiol 2001, 56:485-494.
201. Leibowitz U., Halpern L., Alter M. Clinical studies of multiple sclerosis in Israel. 5. Progressive spinal syndromes and multiple sclerosis. Neurology 1967, 17:988-992.
202. Lennon V.A., Wingerchuk D.M., Kryzer T.J., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
203. Lennon V.A., Kryzer T.J., Pittock S.J., et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473-477.
204. Leroy-Malherbe V., Sebire G., Hollenberg H., et al. Neurogenic bladder in children with acute transverse myelopathy. Arch Pediatr 1998, 5:497-502.
205. Lester E.P., Feld E., Kinzie J.J., et al. Necrotizing myelopathy complicating Hodgkin's disease. Arch Neurol 1979, 36:583-585.
206. Leypoldt F., Eichhorn P., Saager C., et al. Successful immunosuppressive treatment and long-term follow-up of anti-Ri-associated paraneoplastic myelitis. J Neurol Neurosurg Psychiatry 2006, 77:1199-1200.
207. L'hermitte J., Bussière de Robert M.M.E. Myélomalacie et cancers viscéraux. Rev Neurol 1941, 73:611-614.
208. Lin P.H., Chuang T.Y., Liao K.K., et al. Functional recovery of chronic complete idiopathic transverse myelitis after administration of neurotrophic factors. Spinal Cord 2006, 44:254-257.
209. Lins H., Kanakis D., Dietzmann K., et al. Paraneoplastic necrotizing myelopathy with hypertrophy of the cauda equina. J Neurol 2003, 250:1388-1389.
210. Lipton H.L., Teasdall R.D. Acute transverse myelopathy in adults. A follow-up study. Arch Neurol 1973, 28:252-257.
211. Littman B.H. Linear scleroderma: a response to neurologic injury? Report and literature review. J Rheumatol 1989, 16:1135-1140.
212. Longcope W.T. Sarcoidosis, or Benier-Boeck-Schumann disease. JAMA 1941, 117:1321-1327.
213. Low A.A. Acute ascending myelomalacia with clinical picture of Landry's paralysis. CPC report of a case. Arch Neurol Psychiatr (Chic) 1929, 21:594-606.
214. Lubarsch K. Ueber Ruckenmarksveranderungera bei carcinomatosen. Z Klin Med 1897, 31:389.
215. Lubin J.R., Loewenstein J.I., Frederick A.R. Vogt-Koyanagi-Harada syndrome with focal neurologic signs. Am J Ophthalmol 1981, 91:332-341.
216. Lucchinetti C.F., Mandler R.N., McGavern D., et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002, 125:1450-1461.
217. Luque F.A., Furneaux H.M., Ferziger R., et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 1991, 29:241-251.
218. Mair W.G., Folkerts J.F. Necrosis of the spinal cord due to thromboplebitis (subacute necrotic myelitis). Brain 1953, 76:563-757.
219. Manabe Y., Sasaki C., Warita H., et al. Sjögren's syndrome with acute transverse myelopathy as the initial manifestation. J Neurol Sci 2000, 176:158-161.
220. Mancall E.L., Rosales R.K. Necrotizing myelopathy associated with visceral carcinoma. Brain 1964, 87:639-656.
221. Mandler R.N., Ahmed W., Dencoff J.E. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998, 51:1219-1220.
222. Marignier R., De Seze J., Vukusic S., et al. NMO-IgG and Devic's neuromyelitis optica: a French experience. Mult Scler 2008, 14:440-445.
223. Marshall J. Spastic paraplegia of middle age; a clinicopathological study. Lancet 1955, 268:643-646.
224. Marti-Fabregas J., Martinez J.M., Illa I., et al. Myelopathy of unknown etiology. A clinical follow-up and MRI study of 57 cases. Acta Neurol Scand 1989, 80:455-460.
225. Martinelli V., Comi G., Rovaris M., et al. Acute myelopathy of unknown aetiology: a clinical, neurophysiological and MRI study of short- and long-term prognostic factors. J Neurol 1995, 242:497-503.
226. Mascalchi M., Cosottini M., Cellerini M., et al. MRI of spinal cord involvement in Behçet's disease: case report. Neuroradiology 1998, 40:255-257.
227. Matiello M., Lennon V.A., Jacob A., et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008, 70:2197-2200.
228. Matthews W.B. Sarcoidosis of the nervous system. J Neurol Neurosurg Psychiatry 1965, 28:23-29.
229. Medina-Rodriguez F., Garcia E., Fraga A. Transverse myelitis and antiphospholipid antibodies. J Rheumatol 1990, 17:1250.
230. Mehta L.R., Samuelsson M.K., Kleiner A.K., et al. Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome. Mult Scler 2008, 14:425-427.
231. Metreau-Vastel J., Mikaeloff Y., Tardieu M., et al. Neurological involvement in paediatric Behçet's disease. Neuropediatrics 2010, 41:228-234.
232. Mikaeloff Y., Suissa S., Vallee L., et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004, 144:246-252.
233. Miller D.H., Ormerod I.E., Rudge P., et al. The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord. Ann Neurol 1989, 26:635-639.
234. Min J.H., Kim H.J., Kim B.J., et al. Brain abnormalities in Sjögren syndrome with recurrent CNS manifestations: association with neuromyelitis optica. Mult Scler 2009, 15:1069-1076.
235. Miro J., Pena-Sagredo J.L., Berciano J., et al. Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis. Ann Neurol 1990, 27:582-584.
236. Miska R.M., Pojunas K.W., McQuillen M.P. Cranial magnetic resonance imaging in the evaluation of myelopathy of undetermined etiology. Neurology 1987, 37:840-843.
237. Misu T., Fujihara K., Nakashima I., et al. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology 2005, 65:1479-1482.
238. Misu T., Fujihara K., Nakamura M., et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 2006, 209:269-275.
239. Misu T., Fujihara K., Kakita A., et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007, 130:1224-1234.
240. Misumi H., Ishibashi H., Kanayama K., et al. Necrotizing myelopathy associated with hepatocellular carcinoma. Jpn J Med 1988, 27:333-336.
241. Miyata M., Suzuki K., Sakuma F., et al. Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus. Int Arch Allergy Immunol 1993, 100:351-354.
242. Miyazawa R., Ikeuchi Y., Tomomasa T., et al. Determinants of prognosis of acute transverse myelitis in children. Pediatr Int 2003, 45:512-516.
243. Mochizuki A., Hayashi A., Hisahara S., et al. Steroid-responsive Devic's variant in Sjögren's syndrome. Neurology 2000, 54:1391-1392.
244. Moersch F.P., Kernohan J.W. Progressive necrosis of the spinal cord. Arch Neurol Psychiatr (Chic) 1934, 31:504-526.
245. Mok C.C., Lau C.S. Transverse myelopathy complicating mixed connective tissue disease. Clin Neurol Neurosurg 1995, 97:259-260.
246. Mok C.C., Lau C.S., Chan E.Y., et al. Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol 1998, 25(3):467-473.
247. Monastirli A., Chroni E., Georgiou S., et al. Interferon-alpha treatment for acute myelitis and intestinal involvement in severe Behçet's disease. Q J Med 2010, 103:787-790.
248. Montanaro A., Bennett R.M. Myelopathy in Reiter's disease. J Rheumatol 1984, 11:540-541.
249. Morrissey S.P., Miller D.H., Hermaszewski R., et al. Magnetic resonance imaging of the central nervous system in Behçet's disease. Eur Neurol 1993, 33:287-293.
250. Morrissey S.P., Miller D.H., Kendall B.E., et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. Brain 1993, 116:135-146.
251. Moskau S., Urbach H., Hartmann A., et al. Multifocal myelitis in Behçet's disease. Neurology 2003, 60:517.
252. Mueller S., Dubal D.B., Josephson S.A. A case of paraneoplastic myelopathy associated with the neuromyelitis optica antibody. Nat Clin Pract Neurol 2008, 4:284-288.
253. Mullins G.M., Elamin M., Saidha S., et al. Acute aseptic meningitis and diffuse myelitis as the presenting features of neurological Behçet disease. J Clin Neurosci 2009, 16:1702-1704.
254. Nasir S., Kerr D.A., Birnbaum J. Nineteen episodes of recurrent myelitis in a woman with neuromyelitis optica and systemic lupus erythematosus. Arch Neurol 2009, 66:1160-1163.
255. Neuwelt C.M. The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus. Ther Apheresis Dialys 2003, 7:173-182.
256. Newman W., Wolf A. Non-infectious granulomatous angiitis involving the central nervous system. Trans Am Neurol Assoc 1952, 56:114-117.
257. Nikol S., Huehns T.Y., Pilz G., et al. Immune-complex allergic vasculitis in association with the development of transverse myelitis. A case report. Angiology 1996, 47:1107-1110.
258. Nishida T., Ziegler D.K. Acute necrotic myelopathy in association with lymphoma cells of the reticulo-endothelial system, acute torticollis, and recurrent cardiac arrest. Confin Neurol 1973, 35:346-355.
259. Nonne M. Über acute Querlahmung bei maligner Neubildung der Wirbelsäule. Berl Klin Wschr 1903, 40:728.
260. Nonne M. Myelodegeneratio transversa carcino-toxaemica. Med Klinik 1919, 15:943.
261. Noseworthy J.H., Bass B.H., Vandervoort M.K., et al. The prevalence of primary Sjögren's syndrome in a multiple sclerosis population. Ann Neurol 1989, 25:95-98.
262. Nozaki I., Hamaguchi T., Komai K., et al. Fulminant Devic disease successfully treated by lymphocytapheresis. J Neurol Neurosurg Psychiatry 2006, 77:1094-1095.
263. Obara K., Tanaka K. A case of mixed connective tissue disease (MCTD) associated with transverse myelitis responding to pulse therapy. Rinsho shinkeigaku 1991, 31:1197-1201.
264. Oh D.H., Jun J.B., Kim H.T., et al. Transverse myelitis in a patient with long-standing ankylosing spondylitis. Clin Exp Rheumatol 2001, 19:195-196.
265. Ojeda V.J. Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and literature review. Cancer 1984, 53:1115-1123.
266. Okada K., Tsuji S., Tanaka K. Intermittent intravenous immunoglobulin successfully prevents relapses of neuromyelitis optica. Intern Med 2007, 46:1671-1672.
267. Okai A.F., Muppidi S., Bagla R., et al. Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica?. Neurol Res 2006, 28:354-359.
268. O'Riordan J.I., Thompson A.J., Kingsley D.P., et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 1998, 121:495-503.
269. Osoegawa M., Ochi H., Minohara M., et al. Myelitis with atopic diathesis: a nationwide survey of 79 cases in Japan. J Neurol Sci 2003, 209:5-11.
270. Ota K., Tsunemi T., Saito K., et al. 18F-FDG PET successfully detects spinal cord sarcoidosis. J Neurol 2009, 256:1943-1946.
271. Paine R.S., Byers R.K. Transverse myelopathy in childhood. Am J Dis Child 1953, 85:151-163.
272. Pandit L., Rao S. Recurrent myelitis. J Neurol Neurosurg Psychiatry 1996, 60:336-338.
273. Papeix C., Vidal J.S., de Seze J., et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007, 13:256-259.
274. Paty D.W., Blume W.T., Brown W.F., et al. Chronic progressive myelopathy: investigation with CSF electrophoresis, evoked potentials, and CT scan. Ann Neurol 1979, 6:419-424.
275. Paul F., Jarius S., Aktas O., et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med 2007, 4:e133.
276. Paus S., Promse A., Schmidt S., et al. Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology 2003, 61:1022. author reply 1022.
277. Pawate S., Moses H., Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. Q J Med 2009, 102:449-460.
278. Pedersen C., Bonen H., Boesen F. Transverse myelitis in mixed connective tissue disease. Clin Rheumatol 1987, 6:290-292.
279. Perumal J., Zabad R., Caon C., et al. Acute transverse myelitis with normal brain MRI : long-term risk of MS. J Neurol 2008, 255:89-93.
280. Pidcock F.S., Krishnan C., Crawford T.O., et al. Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology 2007, 68:1474-1480.
281. Piper P.G. Disseminated lupus erythematosus with involvement of the spinal cord. JAMA 1953, 153:215-217.
282. Pittock S.J., Lennon V.A. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol 2008, 65:629-632.
283. Pittock S.J., Lucchinetti C.F., Lennon V.A. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 2003, 53:580-587.
284. Pittock S.J., Lucchinetti C.F., Parisi J.E., et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 2005, 58:96-107.
285. Pittock S.J., Weinshenker B.G., Lucchinetti C.F., et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006, 63:964-968.
286. Pittock S.J., Lennon V.A., Krecke K., et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006, 63:390-396.
287. Pittock S.J., Lennon V.A., de Seze J., et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008, 65:78-83.
288. Polman C.H., Reingold S.C., Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria". Ann Neurol 2005, 58:840-846.
289. Polman C., Kappos L., Freedman M.S., et al. Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b. J Neurol 2008, 255:480-487.
290. Poppe A.Y., Lapierre Y., Melancon D., et al. Neuromyelitis optica with hypothalamic involvement. Mult Scler 2005, 11:617-621.
291. Poser S., Herrmann-Gremmels I., Wikstrom J., et al. Clinical features of the spinal form of multiple sclerosis. Acta Neurol Scand 1978, 57:151-158.
292. Pritchard C., Nadarajah K. Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients. Ann Rheum Dis 2004, 63:318-320.
293. Rabadi M.H., Kundi S., Brett D., et al. Neurological pictures. Primary Sjögren syndrome presenting as neuromyelitis optica. J Neurol Neurosurg Psychiatry 2010, 81:213-214.
294. Rajabally Y.A., Qaddoura B., Abbott R.J. Steroid-responsive paraneoplastic demyelinating neuropathy and myelopathy associated with breast carcinoma. J Clin Neuromusc Dis 2008, 10:65-69.
295. Ramos-Remus C., Gomez-Vargas A., Guzman-Guzman J.L., et al. Frequency of atlantoaxial subluxation and neurologic involvement in patients with ankylosing spondylitis. J Rheumatol 1995, 22:2120-2125.
296. Rath J.J., Ronday H.K., Wirtz P.W. Acute transverse myelitis in psoriatic arthritis. J Neurol 2010, 257:457-458.
297. Ravaglia S., Piccolo G., Ceroni M., et al. Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg. J Neurol 2007, 254:1518-1523.
298. Rawlinson D.G., Braun C.W. Granulomatous angiitis of the nervous system first seen as relapsing myelopathy. Arch Neurol 1981, 38:129-131.
299. Renkawek K., Kida E. Combined acute necrotic myelopathy (ANM) and cerebellar degeneration associated with malignant disease. Clin Neuropathol 1983, 2:90-94.
300. Reznik M. Acute ascending poliomyelomalacia after treatment of acute lymphocytic leukemia. Acta Neuropathol 1979, 45:153-157.
301. Richter R.B., Moore R.Y. Non-invasive central nervous system disease associated with lymphoid tumors. Johns Hopkins Med J 1968, 122:271-283.
302. Roemer S.F., Parisi J.E., Lennon V.A., et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130:1194-1205.
303. Ropper A.H., Poskanzer D.C. The prognosis of acute and subacute transverse myelopathy based on early signs and symptoms. Ann Neurol 1978, 4:51-59.
304. Ropper A.H., Ayata C., Adelman L. Vasculitis of the spinal cord. Arch Neurol 2003, 60:1791-1794.
305. Rourke T., Hamidian J.A., Pretorius P., et al. Intraoperative, imaging and pathological features in spinal cord vasculitis. J Clin Neurosci 2009, 16:1093-1095.
306. Rudge P., Webster A.D., Revesz T., et al. Encephalomyelitis in primary hypogammaglobulinaemia. Brain 1996, 119:1-15.
307. Ruet A., Deloire M.S., Ouallet J.C., et al. Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome. Mult Scler 2011, 17:312-318.
308. Ruiz-Arguelles G.J., Guzman-Ramos J., Flores-Flores J., et al. Refractory hiccough heralding transverse myelitis in the primary antiphospholipid syndrome. Lupus 1998, 7:49-50.
309. Saadoun S., Waters P., Bell B.A., et al. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice 2010, 133:349-361.
310. Saiz A., Zuliani L., Blanco Y., et al. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol 2007, 254:1233-1237.
311. Sakushima K., Yabe I., Shiga T., et al. FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis. J Neurol 2011, 258:227-230.
312. Saleh S., Ghodsian S., Yakimova V., et al. Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med 2006, 100:2053-2059.
313. Sandberg-Wollheim M., Axell T., Hansen B.U., et al. Primary Sjögren's syndrome in patients with multiple sclerosis. Neurology 1992, 42:845-847.
314. Santos E., Shaunak S., Renowden S., et al. Treatment of refractory neurosarcoidosis with infliximab. J Neurol Neurosurg Psychiatry 2010, 81:241-246.
315. Schaudinn H. Vorläufiger Bericht über das Vorkommen von Spirochaeten in syphilitischen Krankheitsprodukten und bei Papillomen. Arbeit Kaiserlich Gesundheit 1905, XXII:527-534.
316. Scott T.F., Kassab S.L., Singh S. Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler 2005, 11:373-377.
317. Sebire G., Hollenberg H., Meyer L., et al. High dose methylprednisolone in severe acute transverse myelopathy. Arch Dis Child 1997, 76:167-168.
318. Sebire G., Hollenberg H., Meyer L., et al. High dose methylprednisolone in severe acute transverse myelopathy. Arch Dis Child 1997, 76:167-168.
319. Seifert T., Enzinger C., Ropele S., et al. Relapsing acute transverse myelitis: a specific entity. Eur J Neurol 2005, 12:681-684.
320. Sellner J., Luthi N., Buhler R., et al. Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis. Eur J Neurol 2008, 15:398-405.
321. Semins H., Nugent G.R., Chou S.M. Intramedullary spinal cord sarcoidosis. Case report. J Neurosurg 1972, 37:233-236.
322. Sharp G.C. Mixed connective tissue disease. Bull Rheum Dis 1975, 25:828-831.
323. Sharp G.C., Irvin W.S., Tan E.M., et al. Mixed connective tissue disease - an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972, 52:148-159.
324. Shian W.J., Chi C.S. Acute transverse myelitis in children: clinical analysis of seven cases. Chin Med J 1994, 54:57-61.
325. Shimizu J., Hatanaka Y., Hasegawa M., et al. IFNbeta-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 2010, 75:1423-1427.
326. Sieben G.M., De Reuck J.L., De Bruyne J.C., et al. Subacute necrotic myelopathy. Its appearance eight years after cure of a breast carcinoma. Arch Neurol 1981, 38:775-777.
327. Siekert R.G., Clark E.C. Neurologic signs and symptoms as early manifestations of systemic lupus erythematosus. Neurology 1955, 5:84-88.
328. Sigal L.H. The neurologic presentation of vasculitic and rheumatologic syndromes. A review. Medicine 1987, 66:157-180.
329. Silverstein A., Feuer M.M., Siltzbach L.E. Neurologic sarcoidosis. Study of 18 cases. Arch Neurol 1965, 12:1-11.
330. Simnad V.I., Pisani D.E., Rose J.W. Multiple sclerosis presenting as transverse myelopathy: clinical and MRI features. Neurology 1997, 48:65-73.
331. Sinclair C., Kirk J., Herron B., et al. Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol 2007, 113:187-194.
332. Singer D.H. Pathology of so-called myelitis. Brain 1902, 25:332-340.
333. Siva A., Saip S. The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis. J Neurol 2009, 256:513-529.
334. Sjögren H. Zur Kenntnis der Keratoconjunctivitis sicca: Keratitis filiformis bei Hyopfunktion der Tranendrusen. Acta Opthalmol 1933, (Suppl. 2):1-151.
335. Sjögren H. Zur Kenntnis der Keratoconjunctivitis sicca. II. Allgemeine Symptomatologie und Aetiologie. Acta Opthalmol 1935, 13:1-39.
336. Snyder D.A., Tessler H.H. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1980, 90:69-75.
337. Snyder R., Towfighi J., Gonatas N.K. Sarcoidosis of the spinal cord. Case report. J Neurosurg 1976, 44:740-743.
338. Sofat N., Venables P.J. Is Sjögren myelopathy Devic disease?. Ann Rheum Dis 2008, 67:730-731.
339. Sollberger M., Fluri F., Baumann T., et al. Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol 2004, 251:760-761.
340. Spiegel H.A. Myelomalacia in a three year old child. Report of a case. Arch Pediatr 1936, 53:500-504.
341. Squatrito D., Colagrande S., Emmi L. Devic's syndrome and primary APS: a new immunological overlap. Lupus 2010, 19:1337-1339.
342. Staub H.L., Capobianco K., Neto P.R., et al. Rheumatoid arthritis, transverse myelitis and antiphospholipid antibodies. Clin Exp Rheumatol 1992, 10:626-627.
343. Stich O., Rauer S. Qualitative evidence of anti-Ri specific intrathecal antibody synthesis and quantification of anti-Ri antibodies in serial samples from a patient with anti-Ri syndrome. J Neurol Neurosurg Psychiatry 2006, 77:282-283.
344. Storey E., McKelvie P.A. Necrotizing myelopathy associated with multiple myeloma. Acta Neurol Scand 1991, 84:98-101.
345. Suchett-Kaye A.I. Acute transverse myelitis complicating pneumonia; report of a case. Lancet 1948, 2:417.
346. Tait M.J., Saadoun S., Bell B.A., et al. Water movements in the brain: role of aquaporins. Trends Neurosci 2008, 31:37-43.
347. Takahashi T., Fujihara K., Nakashima I., et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 2006, 210:307-313.
348. Takahashi T., Fujihara K., Nakashima I., et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007, 130:1235-1243.
349. Tan C.T. Prognosis of patients who present with an episode of myelopathy of unknown origin in Malaysia: a retrospective study of 52 patients. Aust N Z J Med 1989, 19:297-302.
350. Tanaka S.T., Stone A.R., Kurzrock E.A. Transverse myelitis in children: long-term urological outcomes. J Urol 2006, 175:1865-1868. discussion 1868.
351. Tanaka M., Matsushita T., Tateishi T., et al. Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis. Neurology 2008, 71:974-981.
352. Tartaglino L.M., Friedman D.P., Flanders A.E., et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995, 195:725-732.
353. Tippett D.S., Fishman P.S., Panitch H.S. Relapsing transverse myelitis. Neurology 1991, 41:703-706.
354. Tomietto P., D'Agostini S., Annese V., et al. Mycophenolate mofetil and intravenous dexamethasone in the treatment of persistent lupus myelitis. J Rheumatol 2007, 34:588-591.
355. Torabi A.M., Patel R.K., Wolfe G.I., et al. Transverse myelitis in systemic sclerosis. Arch Neurol 2004, 61:126-128.
356. Torisu H., Kira R., Ishizaki Y., et al. Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan. Brain Dev 2010, 32:454-462.
357. Toro G., Roman G.C., Navarro-Roman L., et al. Natural history of spinal cord infarction caused by nucleus pulposus embolism. Spine 1994, 19:360-366.
358. Transverse Myelitis Consortium Working Group Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002, 59:499-505.
359. Urai Y., Matsumoto K., Shimamura M., et al. Paraneoplastic necrotizing myelopathy in a patient with advanced esophageal cancer: An autopsied case report. J Neurol Sci 2009, 280:113-117.
360. Van Gehuchten P. Un cas de myélite nécrotique aiguë. Rev Neurol 1927, 1:505-519.
361. Vernant J.C., Cabre P., Smadja D., et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology 1997, 48:58-64.
362. Veron J.P., Escourolle R., Buge A., et al. Acute necrotic myelopathy. Eur Neurol 1974, 11:83-96.
363. Walker A.G. Sarcoidosis of the brain and spinal cord. Postgrad Med J 1961, 37:431-436.
364. Wandinger K.P., Stangel M., Witte T., et al. Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren's syndrome. Arth Rheum 2010, 62:1198-1200.
365. Warabi Y., Matsumoto Y., Hayashi H. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 2007, 252:57-61.
366. Watanabe S., Misu T., Miyazawa I., et al. Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis. Mult Scler 2007, 13:968-974.
367. Watanabe S., Nakashima I., Misu T., et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007, 13:128-132.
368. Weatherby S.J., Davies M.B., Hawkins C.P., et al. Transverse myelopathy, a rare complication of mixed connective tissue disease: comparison with SLE related transverse myelopathy. J Neurol Neurosurg Psychiatry 2000, 68:532-533.
369. Weiler C.R., Bankers-Fulbright J.L. Common variable immunodeficiency: test indications and interpretations. Mayo Clin Proc 2005, 80:1187-1200.
370. Weinshenker B.G., O'Brien P.C., Petterson T.M., et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999, 46:878-886.
371. Weinshenker B.G., Wingerchuk D.M., Vukusic S., et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006, 59:566-569.
372. Weinstock-Guttman B., Ramanathan M., Lincoff N., et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol 2006, 63:957-963.
373. Weiss T.D., Nelson J.S., Woolsey R.M., et al. Transverse myelitis in mixed connective tissue disease. Arth Rheum 1978, 21:982-986.
374. West S.G. Neuropsychiatric lupus. Rheum Dis Clin North Am 1994, 20:129-158.
375. Whiteley A.M., Hauw J.J., Escourolle R. A pathological survey of 41 cases of acute intrinsic spinal cord disease. J Neurol Sci 1979, 42:229-242.
376. Wiederholt W.C., Siekert R.G. Neurological manifestations of sarcoidosis. Neurology 1965, 15:1147-1154.
377. Williams R.A., Billings J.J., De Gruchy G.C. Acute myelitis complicating lymphosarcoma. Med J Aust 1962, 49:128-133.
378. Wilmshurst J.M., Walker M.C., Pohl K.R. Rapid onset transverse myelitis in adolescence: implications for pathogenesis and prognosis. Arch Dis Child 1999, 80:137-142.
379. Wilson J.W., Morales A., Sharp D. Necrotizing myelopathy associated with renal cell carcinoma. Urology 1983, 21:390-392.
380. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999, 53:1107-1114.
381. Wingerchuk D.M., Lennon V.A., Pittock S.J., et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
382. Wingerchuk D.M., Pittock S.J., Lucchinetti C.F., et al. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology 2007, 68:603-605.
383. Wood E.H., Bream C.A. Spinal sarcoidosis. Radiology 1959, 73:226-233.
384. Wyburn-Mason R. Venous abnormalities. The vascular abnormalities and tumours of the spinal cord and its membranes 1943, 1-196. Henry Kimpton, London.
385. Yamaguchi Y., Yoshimura T., Hosokawa S., et al. A case of mixed connective tissue disease with subacute transverse myelopathy. Rinsho shinkeigaku 1991, 31(10):1099-1102.
386. Yamasaki K., Horiuchi I., Minohara M., et al. Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med 2000, 39:296-299.
387. Yiu E.M., Kornberg A.J., Ryan M.M., et al. Acute transverse myelitis and acute disseminated encephalomyelitis in childhood: spectrum or separate entities?. J Child Neurol 2009, 24:287-296.
388. Yoshioka H., Matsubara T., Miyanomae Y., et al. Spinal cord MRI in neuro-Behçet's disease. Neuroradiology 1996, 38:661-662.
389. Young J., Quinn S., Hurrell M., et al. Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler 2009, 15:1295-1302.
390. Yucesan C., Arslan O., Arat M., et al. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases. Transfus Apher Sci 2007, 36:103-107.
391. Zajicek J.P., Scolding N.J., Foster O., et al. Central nervous system sarcoidosis - diagnosis and management. Q J Med 1999, 92:103-117.
392. Zandman-Goddard G., Levy Y., Weiss P., et al. Transverse myelitis associated with chronic hepatitis C. Clin Exp Rheumatol 2003, 21:111-113.
393. Zeng X.N., Sun X.L., Gao L., et al. Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes. Mol Cell Neurosci 2007, 34:34-39.
394. Zoli A., Mariano M., Fusari A., et al. Atopic myelitis: first case report outside Japan?. Allergy 2005, 60:410-411.